Genscript Biotech Corporation

SEHK:1548 Stock Report

Market Cap: HK$37.5b

Genscript Biotech Future Growth

Future criteria checks 3/6

Genscript Biotech is forecast to grow earnings and revenue by 91.9% and 2.8% per annum respectively. EPS is expected to grow by 91% per annum. Return on equity is forecast to be 3.9% in 3 years.

Key information

91.9%

Earnings growth rate

91.04%

EPS growth rate

Life Sciences earnings growth29.9%
Revenue growth rate2.8%
Future return on equity3.90%
Analyst coverage

Good

Last updated25 Aug 2025

Recent future growth updates

Recent updates

We Think You Can Look Beyond Genscript Biotech's (HKG:1548) Lackluster Earnings

Sep 18
We Think You Can Look Beyond Genscript Biotech's (HKG:1548) Lackluster Earnings

Genscript Biotech (HKG:1548) Has A Pretty Healthy Balance Sheet

Sep 08
Genscript Biotech (HKG:1548) Has A Pretty Healthy Balance Sheet

Genscript Biotech Corporation's (HKG:1548) 28% Price Boost Is Out Of Tune With Revenues

Jul 29
Genscript Biotech Corporation's (HKG:1548) 28% Price Boost Is Out Of Tune With Revenues

At HK$18.16, Is It Time To Put Genscript Biotech Corporation (HKG:1548) On Your Watch List?

Jul 24
At HK$18.16, Is It Time To Put Genscript Biotech Corporation (HKG:1548) On Your Watch List?
User avatar

Global Demand Rebound Will Drive Life Sciences And CDMO Expansion

Expansion in global markets, technology upgrades, and industry partnerships are set to drive stronger growth, improved margins, and long-term earnings stability.

Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

May 14
Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Genscript Biotech Corporation (HKG:1548) May Have Run Too Fast Too Soon With Recent 27% Price Plummet

Apr 07
Genscript Biotech Corporation (HKG:1548) May Have Run Too Fast Too Soon With Recent 27% Price Plummet

Investors Still Aren't Entirely Convinced By Genscript Biotech Corporation's (HKG:1548) Revenues Despite 27% Price Jump

Feb 12
Investors Still Aren't Entirely Convinced By Genscript Biotech Corporation's (HKG:1548) Revenues Despite 27% Price Jump

Genscript Biotech Corporation (HKG:1548) Shares Could Be 49% Below Their Intrinsic Value Estimate

Jan 20
Genscript Biotech Corporation (HKG:1548) Shares Could Be 49% Below Their Intrinsic Value Estimate

Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)

Nov 19
Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)

Earnings and Revenue Growth Forecasts

SEHK:1548 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20279212958023910
12/31/2026809993925810
12/31/202594966892228
6/30/20258285126228N/A
3/31/2025711-312152N/A
12/31/2024594-67-12176N/A
6/30/2024454419-276-20N/A
3/31/2024507421-410-153N/A
12/31/2023560423-543-287N/A
9/30/2023773-140-506-266N/A
6/30/2023707-185-523-245N/A
3/31/2023667-206-431-183N/A
12/31/2022626-227-339-120N/A
9/30/2022598-315-321-142N/A
6/30/2022570-403-304-163N/A
3/31/2022530-381-289-150N/A
12/31/2021490-359-274-137N/A
9/30/2021483-265-265-127N/A
6/30/2021454-183-256-118N/A
3/31/2021422-194-268-134N/A
12/31/2020391-205-279-151N/A
9/30/2020354-194-171-48N/A
6/30/2020318-183-6454N/A
3/31/2020296-140-10312N/A
12/31/2019273-97-142-30N/A
9/30/2019257-59-207-116N/A
6/30/2019241-22-272-202N/A
3/31/20192360N/A53N/A
12/31/201823121N/A308N/A
9/30/201821624N/A338N/A
6/30/201820127N/A369N/A
3/31/201817726N/A195N/A
12/31/201715326N/A21N/A
9/30/201713927N/A24N/A
6/30/201712528N/A27N/A
3/31/201712027N/A30N/A
12/31/201611526N/A33N/A
9/30/201610726N/A29N/A
6/30/20169925N/A25N/A
3/31/20169321N/A22N/A
12/31/20158718N/A20N/A
9/30/20158213N/A18N/A
6/30/2015788N/A16N/A
3/31/2015747N/A14N/A
12/31/2014706N/A12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1548's forecast earnings growth (91.9% per year) is above the savings rate (2.7%).

Earnings vs Market: 1548's earnings (91.9% per year) are forecast to grow faster than the Hong Kong market (12.9% per year).

High Growth Earnings: 1548's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1548's revenue (2.8% per year) is forecast to grow slower than the Hong Kong market (8.7% per year).

High Growth Revenue: 1548's revenue (2.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1548's Return on Equity is forecast to be low in 3 years time (3.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 04:19
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genscript Biotech Corporation is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin ZhangChina International Capital Corporation Limited
Shitong HanCitic Securities Co., Ltd.
Zhu ChenCitic Securities Co., Ltd.